Crossmark

Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy

Crossref DOI link: https://doi.org/10.1038/s41420-021-00812-6

Published Online: 2022-01-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Särchen, Vinzenz https://orcid.org/0000-0001-9565-2850
Shanmugalingam, Senthan

Kehr, Sarah

Reindl, Lisa Marie https://orcid.org/0000-0002-1027-1256
Greze, Victoria

Wiedemann, Sara

Boedicker, Cathinka

Jacob, Maureen

Bankov, Katrin

Becker, Nina

Wehner, Sibylle

Theilen, Till M.

Gretser, Steffen https://orcid.org/0000-0002-4875-3808
Gradhand, Elise

Kummerow, Carsten https://orcid.org/0000-0001-5667-2293
Ullrich, Evelyn

Vogler, Meike https://orcid.org/0000-0003-2650-586X
Funding

Funding for this research was provided by:

Deutsche Krebshilfe (70113791)

Deutsche Krebshilfe (70113791)

Deutsche Krebshilfe (70112823)

Madeleine Schickedanz Kinderkrebsstiftung

Deutsche Forschungsgemeinschaft (CRC 1292 - IRTG)

Deutsche Forschungsgemeinschaft (INST 256/423-1 FUGG)

Deutsche Forschungsgemeinschaft (CRC 1292)
License Information

Text and Data Mining valid from 2022-01-10

Version of Record valid from 2022-01-10
More Information

Article History

Received: 29 September 2021

Revised: 3 December 2021

Accepted: 16 December 2021

First Online: 10 January 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below